 I'm Professor Larry Chambers and I'm the chair of the Knowledge Translation Committee of the Canadian Long-Tunnel Study on Aging. The Canadian Long-Tunnel Study on Aging is different from other studies for a number of reasons. One of them is that it's following people over a 20-year period. It's also following a very large number of people over 20 years, 50,000 people. There are very few studies of this kind that have ever been done in history in other countries, and certainly the first in Canada of this kind. And finally, it's unique in the sense that it's gathering data on both nature and nurture. We're born with certain characteristics because of our genes and who our parents are, etc. And then in addition, we are exposed to a number of things during our lifetime that we call the nurture. We also have different types of support that we receive during that time. We have different occupations, etc. And this will be a very full examination of those kinds of issues. And to see what comes first, the characteristic, and then the disease, for example, or does the disease come first and then other issues start to come up. Well, first of all, the Canadian long-term study in aging will be of great interest to those people in the Canadian public that are interested in their health and living to a ripe old age and being able to function during that whole time. That's certainly a goal of mine to just keep going and be physically and mentally alert till it's all over. The second group are, of course, policymakers that have to make decisions about health services in this country. The extent to which chronic disease is a huge issue in our health care system as the Canadian population becomes, quote, older, as baby boomers are increasing the number of people who are over 65. And, of course, chronic disease is most prevalent in that group. And finally, researchers will have great interest in the long-term study because, as I said earlier, the uniqueness of the study, the fact that the study follows people for 20 years, the very large number of people, 50,000 people, we'll be able to look at more or less frequent diseases, less frequent characteristics than most studies are able to examine. Our challenge with the knowledge exchange and translation work of the Canadian Long-Tunnel Study in Aging is to make that evidence available through a multiplicity of facilitation methods, through media, through conferences, through scientific papers, through support groups, through new things like Facebook and Twitter, et cetera, and also making sure that those organizations and those individuals that are keen to get the information we contact and make sure they receive it. I would like to just point out again that the Canadian Long-Tunnel Study is a fantastic study and I feel very privileged to be part of it and we're very privileged in Canada to have this kind of work going on and the kinds of things that we're able to do with this study is a huge breakthrough in science in Canada. The second thing is in discussions I've had with people outside the country, international researchers and experts, they are all in agreement that we have a world-class study and it's probably the best in the world.